11:37 AM EST - VentriPoint Diagnostics Ltd : Announced that it has received market clearance from the U.S. Food and Drug Administration to sell its VMS+™ machine with the four-chamber heart analysis system in the United States. The intended use is for the analysis of ejection fraction (function) and volumes of any chamber of the heart, where they are warranted or desired. VentriPoint Diagnostics Ltd
shares V.VPT are trading up $0.12 at $0.42.
